Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF-Endoret versus corticosteroid injection for rotator cuff tendinopathy
2012-001056-19Phase 3Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of PRGF-Endoret, betamethasone sodium phosphate + betamethasone acetate and betamethasone in shoulder tendinopathy (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias. Started Aug 2013; status: completed.
02
Drugs
PRGF-Endoretbetamethasone sodium phosphate + betamethasone acetatebetamethasone
03
Conditions
shoulder tendinopathy
Beyond the preview
Go deeper on 2012-001056-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001056-19.